Overview

December 22, 2020

[Yakuji Nippo]Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients

Life Data Initiative (LDI), NTT DATA Corporation, and Pfizer Inc. made an announcement on the December 14th that the three...

Target market

Japan
Business category

Pharmaceutical, Biopharmaceutical, Regerative medicine, Medical device, Digital health, Others
Business function

Marketing >
Keyword
Author

"LSMIP Editorial Office" of "CM Plus Corporation"
Availability

Membership

Detail

株式会社薬事日報社から許諾を受けて、株式会社シーエムプラスが英語に翻訳しております。
オリジナルの正式言語は日本語であり、内容および解釈については日本語が優先されます。
With permission from Yakuji Nippo, Limited, CM Plus Corporation translated into English.
The original article is authored in Japanese, and the Japanese shall prevail in meaning in terms of content and interpretation.

Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients
December 16th, 2020

Life Data Initiative (LDI), NTT DATA Corporation, and Pfizer Inc. made an announcement on the December 14th that the three would analyze medical big data including electronic medical record information and advance the research on the methodology to assess clinical outcome of cancer patients. The three entered a contract which aimed to provide anonymously processed medical information based on the Next Generation Medical Infrastructure Act, and they will make beneficial use of research findings for the development of personalized medicine, early development of pharmaceuticals, and so forth.

(Continue to the next)

For this translated article in English, CM Plus Corporation shall have the copyright.
Unauthorized reproduction of posted articles, photos, diagrams, etc. is prohibited.
Copyright © 2020 LSMIP office / CM Plus Singapore Pte. Ltd.

Read Article

Overview

[Yakuji Nippo]Collaborative Research with Data Analysis – Three Companies including LDI Assess the Outcome of Cancer Patients

Detail

Comments (Require approval)